Adam E. Snook

3.5k total citations
118 papers, 2.4k citations indexed

About

Adam E. Snook is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Adam E. Snook has authored 118 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 48 papers in Immunology and 36 papers in Molecular Biology. Recurrent topics in Adam E. Snook's work include CAR-T cell therapy research (33 papers), Immunotherapy and Immune Responses (32 papers) and Cancer Research and Treatments (21 papers). Adam E. Snook is often cited by papers focused on CAR-T cell therapy research (33 papers), Immunotherapy and Immune Responses (32 papers) and Cancer Research and Treatments (21 papers). Adam E. Snook collaborates with scholars based in United States, Germany and Belgium. Adam E. Snook's co-authors include Scott A. Waldman, Michael S. Magee, John C. Flickinger, Trevor R. Baybutt, Jieru E. Lin, Terry Hyslop, Stephanie Schulz, Glen P. Marszalowicz, Dante J. Merlino and Robert D. Carlson and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Adam E. Snook

115 papers receiving 2.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Adam E. Snook	985	799	757	324	285	118	2.4k
Sara M. Mangsbo	892 0.9×	500 0.6×	1.1k 1.4×	229 0.7×	198 0.7×	65	2.1k
Mohanraj Ramachandran	916 0.9×	1.1k 1.3×	560 0.7×	96 0.3×	331 1.2×	46	3.5k
Vasu Punj	786 0.8×	1.9k 2.4×	393 0.5×	135 0.4×	291 1.0×	79	3.4k
Nasrollah Erfani	903 0.9×	843 1.1×	936 1.2×	191 0.6×	205 0.7×	127	2.3k
F. Schlemmer	1.2k 1.2×	702 0.9×	1.4k 1.9×	79 0.2×	139 0.5×	51	3.0k
Hua Peng	1.0k 1.0×	1.1k 1.4×	1.7k 2.2×	175 0.5×	187 0.7×	67	3.4k
Yoshikazu Tsuzuki	435 0.4×	840 1.1×	513 0.7×	137 0.4×	306 1.1×	78	2.3k
Hailing Lu	977 1.0×	772 1.0×	1.4k 1.8×	249 0.8×	147 0.5×	63	2.4k
Weiqi Hong	561 0.6×	1.7k 2.2×	544 0.7×	117 0.4×	260 0.9×	43	3.4k

Countries citing papers authored by Adam E. Snook

Since Specialization

Citations

This map shows the geographic impact of Adam E. Snook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam E. Snook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam E. Snook more than expected).

Fields of papers citing papers by Adam E. Snook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam E. Snook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam E. Snook. The network helps show where Adam E. Snook may publish in the future.

Co-authorship network of co-authors of Adam E. Snook

This figure shows the co-authorship network connecting the top 25 collaborators of Adam E. Snook. A scholar is included among the top collaborators of Adam E. Snook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam E. Snook. Adam E. Snook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Snook, Adam E., et al.. (2024). Biomarkers for Managing Neurodegenerative Diseases. Biomolecules. 14(4). 398–398. 12 indexed citations

Byrne, Matthew, et al.. (2024). GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults. npj Parkinson s Disease. 10(1). 4 indexed citations

Snook, Adam E., Guido Ghilardi, Steven Yang, et al.. (2023). Senza5 TM CART5: An Autologous CD5-Deleted Anti-CD5 CART Product with Enhanced Anti-T-Cell Lymphoma Activity. Blood. 142(Supplement 1). 3462–3462. 1 indexed citations

Hughes, Ryan T., Varsha Gandhi, Adam E. Snook, Scott A. Waldman, & Adam C. Mueller. (2023). Gamma Secretase Inhibition Sensitizes Pancreatic Adenocarcinoma Tumors to RT In Vivo. International Journal of Radiation Oncology*Biology*Physics. 117(2). S103–S104. 1 indexed citations

Crutcher, Madison, et al.. (2022). Guanylyl Cyclase C as a Diagnostic and Therapeutic Target in Colorectal Cancer. Personalized Medicine. 19(5). 457–472. 5 indexed citations

Flickinger, John C., Jagmohan Singh, Robert D. Carlson, et al.. (2022). Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy. npj Vaccines. 7(1). 61–61. 11 indexed citations

Alexander, Tyler D., Lan Cheng, Angelo C. Lepore, et al.. (2022). Intestinal neuropod cell GUCY2C regulates visceral pain. Journal of Clinical Investigation. 133(4). 13 indexed citations

Huang, Jianhe, Hongbin Luo, Jagmohan Singh, et al.. (2021). Functional Assessment of Missense Variants in the ABCC6 Gene Implicated in Pseudoxanthoma Elasticum, a Heritable Ectopic Mineralization Disorder. Journal of Investigative Dermatology. 142(4). 1085–1093. 1 indexed citations

Flickinger, John C., et al.. (2021). Guanylyl Cyclase C As A Biomarker for Immunotherapies for the Treatment of Gastrointestinal Malignancies. Biomarkers in Medicine. 15(3). 201–217. 1 indexed citations

10.

Snook, Adam E., et al.. (2021). Emerging Targets for the Diagnosis of Parkinson’S Disease: Examination of Systemic Biomarkers. Biomarkers in Medicine. 15(8). 597–608. 2 indexed citations

11.

Rappaport, Jeffrey A., Signe Caksa, Aakash Jhaveri, et al.. (2021). A β-Catenin-TCF-Sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal Cancer. Cellular and Molecular Gastroenterology and Hepatology. 13(4). 1276–1296. 9 indexed citations

12.

Snook, Adam E., et al.. (2021). Stem Cells as Therapeutic Targets in Colorectal Cancer. Personalized Medicine. 18(2). 171–183. 12 indexed citations

13.

Lin, Abraham, Fred C. Krebs, Adam E. Snook, et al.. (2019). Non-thermal plasma-induced immunogenic cell death in cancer. Journal of Physics D Applied Physics. 52(42). 423001–423001. 75 indexed citations

14.

Magee, Michael S., Tara S. Abraham, Trevor R. Baybutt, et al.. (2018). Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases. Cancer Immunology Research. 6(5). 509–516. 115 indexed citations

15.

Li, Peng, Evan Wuthrick, Jeffrey A. Rappaport, et al.. (2017). GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome. Cancer Research. 77(18). 5095–5106. 12 indexed citations

16.

Lin, Jieru E., Francheska Colón‐González, Erik Blomain, et al.. (2016). Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin–GUCY2C Paracrine Signaling Axis. Cancer Research. 76(2). 339–346. 47 indexed citations

17.

Lin, Jieru E., Peng Li, Adam E. Snook, et al.. (2014). The Paracrine Hormone for the GUCY2C Tumor Suppressor, Guanylin, Is Universally Lost in Colorectal Cancer. Cancer Epidemiology Biomarkers & Prevention. 23(11). 2328–2337. 49 indexed citations

18.

Hayes, Candace S., et al.. (2013). Polyamine-Blocking Therapy Reverses Immunosuppression in the Tumor Microenvironment. Cancer Immunology Research. 2(3). 274–285. 132 indexed citations

19.

Lin, Jieru E., Gilbert W. Kim, Glen P. Marszalowicz, et al.. (2013). Intestinal GUCY2C Prevents TGF-β Secretion Coordinating Desmoplasia and Hyperproliferation in Colorectal Cancer. Cancer Research. 73(22). 6654–6666. 20 indexed citations

20.

Comber, Joseph D., et al.. (2011). Functional Macroautophagy Induction by Influenza A Virus without a Contribution to Major Histocompatibility Complex Class II-Restricted Presentation. Journal of Virology. 85(13). 6453–6463. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact